News

Evidation Insights from 165,000 People Show Continued Growth Potential Amid Uneven Adoption in the GLP-1 Market

Among 119,000 surveyed individuals actively trying to lose weight, 24% had ever used prescription medication for weight management and 15% had ever used a GLP-1, suggesting significant room for continued market growth as adoption varies by age, gender, and income.

Evidation Launches Interactive Dermatology Cohort; Shares Preliminary Real-World Insights

New cohort is designed to address gaps in understanding treatment journeys across the full continuum of care. Insights show that consumer health products play a critical part in how individuals understand and manage their skin conditions.

Evidation partners with 1upHealth to integrate diverse sources of permissioned real-world health data for research

Evidation and 1upHealth announce a long-term partnership to advance patient-centered, real-world health research.

Evidation Launches Temporal Proteomics Platform to Power Autoimmune Research

New AI-enabled data collection platform will drive the development of novel multimodal datasets for biomarker discovery, treatment-response modeling, and foundation models of the immune system.

Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals

New insights from Evidation’s cardiometabolic health and weight management cohort, comprised of over 160,000 individuals, show what factors shape real-world dosing decisions.

Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer

Evidation appoints Dr. Ghazanfar Khan as Chief Medical Officer. Dr. Khan will advance Evidation’s leadership in real-world data by driving the clinical strategy for direct-to-participant multimodal data collection to fuel AI-powered discovery and evidence generation.

Evidation Appoints Leslie Oley Wilberforce as CEO

Evidation appoints Leslie Oley Wilberforce as CEO. Wilberforce will lead Evidation’s next phase of growth in interactive real-world data and health research.

Evidation appoints Phil Johnson as Chief Commercial Officer

Evidation announces the addition of a new Chief Commercial Officer, Phil Johnson, and board member, Ian Lennox.

Trialbee and Evidation partner to accelerate and diversify clinical research recruitment

Learn how Evidation and Trialbee's joint offering and shared commitment to inclusion and data transparency drives enrollment outcomes.

Rock Health shares findings from weight care survey with Evidation

Evidation helped Rock Health conduct surveys that investigated experience and perceptions of a variety of weight care solutions. Read key highlights here.